Angelina Jolie takes bio-identical estrogen delivered through a clear patch and progesterone via an intrauterine device (IUD).
Following preventative surgeries, including the removal of her ovaries to reduce cancer risk, Jolie began hormone therapy to manage the symptoms of menopause and further prevent potential health issues.
Hormones and Delivery Methods
Jolie's hormone regimen is specifically tailored to address her needs after her preventative health measures. The two primary hormones she utilizes are:
- Estrogen: This hormone is delivered transdermally via a clear patch. Its primary purpose for Jolie is to alleviate the symptoms associated with menopause, which can arise following the removal of ovaries.
- Progesterone: Administered through an intrauterine device (IUD), progesterone is used to help protect against uterine cancer. This is a crucial component of hormone therapy, especially when estrogen is also being used, as progesterone helps to balance estrogen's effects on the uterine lining.
Hormone | Delivery Method | Primary Purpose (for Jolie) |
---|---|---|
Estrogen | Clear transdermal patch | To curb symptoms of menopause |
Progesterone | Intrauterine Device (IUD) | To help prevent uterine cancer |
Understanding Bio-identical Hormones
The term "bio-identical" refers to hormones that are chemically identical to those naturally produced by the human body. While the body cannot distinguish between hormones it produces and bio-identical hormones, their use, effectiveness, and potential risks are subjects of ongoing scientific discussion within the medical community.
Angelina Jolie's choice to use these specific hormones and delivery methods is part of her comprehensive health management strategy, particularly after undergoing procedures to mitigate her risk of certain cancers. This approach aims to address post-operative symptoms and provide additional protective benefits. For more information on hormone therapy and its implications, you can refer to reputable health resources such as Today.com's discussion on bio-identical therapy.